Predictive Elements of Trauma and Its After-effects: Importance of the Quality of Neurobiological Response to Stress
LIFT-UP
2 other identifiers
observational
130
1 country
4
Brief Summary
The neurobiological response to stress is an adaptive response allowing us to cope with the multiple aggressions of daily life. This response orchestrates the body's systemic reaction. The intensity of response to stress can modify the body's functioning, which implies a variety of fields where biomarkers may be isolated: immunity, psychology, neurophysiology, integrative physiology. When stress is too intense or prolonged, response to stress may become misfitted and deleterious. This study is based on the hypothesis that a severe physical or psychological trauma is associated with an intense and misfitted stress that is responsible from an undue immuno-inflammatory activation (through sympathetic activation). The result is a subinvasive state of systemic and tissue inflammation (low-noise inflammation), responsible for the mid-term deleterious consequences of the traumatic event. The objective of this study is to understand how the dysregulation of intense stress simultaneously generates an initial pathological state and an alteration of mid-term evolution (which is considered as a poor prognosis and/or as responsible for after-effects). The investigators wish to identify relevant biomarkers of the mechanisms activated during intense stress and influencing the immuno-inflammatory and epigenetic spheres with deleterious consequences on physiological and psychological functions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2020
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2020
CompletedFirst Posted
Study publicly available on registry
August 28, 2020
CompletedStudy Start
First participant enrolled
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedApril 28, 2023
April 1, 2023
2.5 years
August 25, 2020
April 27, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Occurrence of depression
Screening for depression will be done using a validated self-report questionnaire, the Geriatric Depression Scale Short Version (GDS). We will use the threshold value of 10 (score \> or =) which corresponds to a very high probability of depression.
12 months following surgery
Occurrence of "psychosomatic death"
The diagnosis of "psychosomatic death" will be made by a physician. There is no consensus on the diagnosis of this syndrome. However, a patient with "psychosomatic death" is likely to be hospitalized or followed up medically and will not be able to respond to the investigator's request for a telephone interview.
12 months following surgery
Occurrence of death
Vital status will be collected from the participant's family or referring physician or at the birth \& death record service (of the participant's town)
12 months following surgery
Secondary Outcomes (16)
Evolution of heart rate variability between enrollment and Visit 1
Between enrollment and Visit 1 (45-60 days following surgery)
Evolution of perceived stress level between enrollment and Visit 1
Between enrollment and Visit 1 (45-60 days following surgery)
Evolution of anxiety level between enrollment and Visit 1
Between enrollment and Visit 1 (45-60 days following surgery)
Evolution of post-traumatic stress disorder severity level between enrollment and Visit 1
Between enrollment and Visit 1 (45-60 days following surgery)
Evolution of quality of life between enrollment and Visit 1
Between enrollment and Visit 1 (45-60 days following surgery)
- +11 more secondary outcomes
Interventions
Blood collection at enrollment (before surgery) and at Visit 1 (45-60 days following surgery)
Saliva collection at enrollment (before surgery) and at Visit 1 (45-60 days following surgery)
Electrocardiography (ECG) at enrollment (24-72h following surgery) and at Visit 1 (45-60 days following surgery) to assess heart rate variability
Mental health assessment through questionnaires at enrollment (24-72h following surgery), at Visit 1 (45-60 days following surgery), at Visit 2 (7 months following surgery) and at Visit 3 (12 months following surgery)
Eligibility Criteria
Patients admitted to the emergency room for a fracture of the upper end of the femur.
You may qualify if:
- Fracture of the upper end of the femur
- Cognitive state allowing the understanding of questionnaires
You may not qualify if:
- Traumatic Brain Injury
- Chronic inflammatory or immune pathologies
- On anticoagulants
- On neuroleptic or antidepressant treatment
- Pathology or health condition not allowing 1-year survival
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CHU Pellegrin
Bordeaux, 33000, France
Hôpital d'Instruction des Armées Percy
Clamart, 92140, France
Hôpital d'Instruction des Armées Bégin
Saint-Mandé, 94163, France
Hôpital d'Instruction des Armées Sainte-Anne
Toulon, 83800, France
Biospecimen
Blood samples and saliva samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2020
First Posted
August 28, 2020
Study Start
November 4, 2020
Primary Completion
May 1, 2023
Study Completion
May 1, 2023
Last Updated
April 28, 2023
Record last verified: 2023-04